Inductive Bio Job Trends
2
Active Jobs (Last 14 Days)
1
Fresh Jobs (Last 3 Days)
100%
Jobs with Salary Data
Recent Job Posting Activity (30 Days)
Job Category Distribution
Current Inductive Bio Jobs, Salary Data, and Stats
In the last two weeks, Inductive Bio has posted 2 positions. None of those roles offer remote or hybrid work. We've been tracking Inductive Bio since May 21, 2025.
Career Tracks Currently Hiring
Currently Hiring Office Locations
New York City, San Francisco, or Boston New York CityCurrent Inductive Bio Jobs
Last updated: Apr 20, 2026
Showing 2 active jobs. Active jobs were posted in the last 14 days. Fresh jobs were posted within the last 3 days. Click a row for more details.
Showing filtered results for ""
| Role | |
|---|---|
Medicinal ChemistFresh
Research
Apr 20 $210,000 - $250,000 New York City, San Francisco, or Boston Apply →Medicinal ChemistApply →Fresh
Research
Apr 20 $210,000 - $250,000
New York City, San Francisco, or BostonInductive Bio is an AI medicinal chemistry partner. We build virtual labs that help drug discovery teams make better decisions, faster, across the full DMTA cycle. Our platform includes Beacon-1 ADMET prediction models, human dose projection tools, and Indy, an AI medicinal chemistry assistant. Through partnerships with CROs, we also offer innovative synthesis approaches, direct-to-dose testing, and cost-effective tier 1 ADME panels that enable initial human PK projection, closing the loop from computational design to experimental validation. Together, these power dozens of small molecule and beyond-rule-of-five programs for biotech and pharma partners. Beacon-1 placed 1st in both the 2025 Polaris... | |
Product Scientist (Computational Chemist)Comm
Apr 7 $180,000 - $220,000 New York City, San Francisco, or Boston Apply →Product Scientist (Computational Chemist)Apply →Comm
Apr 7 $180,000 - $220,000
New York City, San Francisco, or BostonInductive Bio is an AI medicinal chemistry partner. We build virtual labs that help drug discovery teams make better decisions, faster, across the full DMTA cycle. Our platform includes Beacon-1 ADMET prediction models, human dose projection tools, and Indy, an AI medicinal chemistry assistant. Through a partnership with Enamine, we also offer library synthesis and direct-to-dose testing, closing the loop from computational design to experimental validation. Together, these power dozens of small molecule and beyond-rule-of-five programs for biotech and pharma partners. Beacon-1 placed 1st in both the 2025 Polaris and 2026 OpenADMET-ExpansionRx blind competitions, ahead of Merck & Co +... | |